Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cure Rare Disease

News headline image
Cure Rare Disease Awarded $7.4 Million CIRM Grant to Advance Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2i/R9
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9)
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Receives FDA Feedback on Limb-Girdle 2i/R9 Gene Therapy Program Following Successful Pre-IND Meeting
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Welcomes New Scientific and Strategic Leaders to Advance Therapies for Ultra-Rare Conditions
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Receives Orphan Drug Designation from FDA for Investigational Therapy Targeting Spinocerebellar Ataxia Type 3 (SCA3)
From Cure Rare Disease
Via Business Wire
News headline image
We Row For William: 157 Miles, One Nonstop Journey of Hope
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Awarded $5.69 Million CIRM Grant to Advance Gene Therapy for Spinocerebellar Ataxia Type 3
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Welcomes Leading Experts to Scientific Advisory Board
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Receives Muscular Dystrophy Association Grant
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Acquires Laboratory Space for New Headquarters in Connecticut
From Cure Rare Disease
Via Business Wire
News headline image
Cure Rare Disease Receives FDA Approval to Administer First-in-Human CRISPR Therapeutic
From Cure Rare Disease
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.